September 23, 2015
Bellafill, previously known as Artefill, has made major waves in the cosmetic world since releasing five-year safety and efficacy data on September 15th. This study is the largest and longest prospective dermal filler study to date, according to Suneva, the manufacturer of Bellafill.
For those who have been paying for injectable treatments every 6-18 months, this is incredibly exciting news that almost sounds too good to be true. So is it? Not necessarily, but for some…yes.
Bellafill Vs Other Fillers
Fillers such as Juvederm and Restylane are made of hyaluronic acid, which is naturally found in the skin and re-absorbed by the body over time. By contrast, Bellafill contains a percentage of microspheres that are not absorbed by the body, making Bellafill a “semi-permanent” filler.
Pros & Cons of Bellafill
The fact that Bellafill is “semi-permanent” is considered a pro for many but can be a major con as well. If a patient isn’t happy with their result, they can’t just wait until it’s absorbed by the body. They also can’t have it broken down with hyaluronidase, an injectable that can easily break down hyaluronic acid fillers. A Bellafill patient either lives with the undesireable result or has to have the filler surgically removed from the skin. And even if a patient is happy with their results initially, the face continues to age and they may not like the way everything looks 10 years down the road.
Currently, the most popular dermal fillers are hyaluronic acid fillers by far. Most reputable physicians have used permanent or semi-permanent fillers judiciously or not at all because of the long-term concerns. When interviewed by Cosmetic Surgery Times, Dr. Paul Nassif, facial plastic surgeon in Beverly Hills (also from E’s “Botched”) stated: “I have known about Bellafill for a while, but still don’t use it with my patients. I have always been conservative when it comes to permanent or non-reversible fillers (like Bellafill), but will continue to evaluate Bellafill and its role in my practice – especially in light of this new research.”
Also interviewed was Dr. Cohen, a clinical professor of plastic surgery at the University of California, San Diego. He believes, “the strong support evidence of Bellafill’s safety profile supplies data that all physicians to use the filler with confidence.”
At Utah Facial Plastics, a premier center for injectables in Utah, Dr. Scott Thompson primarily uses hyaluronic acid fillers because of the same concerns mentioned above. He does treat patients who specifically request Bellafill as long as they are aware of the concerns and will continue to evaluate its safety and efficacy before strongly encouraging the option over other reputable products.
For more information on the study, visit CosmeticSurgeryTimes.org. And to discuss this and other injectables for facial rejuvenation, Utah Facial Plastics can be reached at (801)776-2220.Tags: acne scars, bellafill, dermal filler, injectables, juvederm, non-surgical, restylane
This post was written by Jenny Yergensen